PAB

0.00%

0.6¢ patrys limited

I direct your attention to: Chairman’s Address and CEO...

First 60 Last

Share
Profile

Follow
Curlyjoh

1,743 Posts.

222

21/06/22

14:55

Post #: 62115313
Share

Originally posted by JonesingPanda ↑

"DX1 and DX3 have all the hallmarks of a potential buyout - all these animal studies showing multiple novel characteristics of the DX family + the news of an imminent phase I trial will in my opinion definitely position Patrys well for a pre-clinical buyout."

My thoughts are if the company announces their launch of phase 1 trials then there won't be a buyout until the results of that trial come through. Best case for investors is a big pharma will put an offer on the table that is dependent on the results, with an initial immediate payment that may supplement phase 1 costs.

Otherwise if Patrys already has enough money to get through phase 1 trials, they're better off getting the safety data before allowing a buyout in say a years time. If they're months from starting phase 1, looking at the SP now you have to ask how much the top holders have to gain from a buyout now vs in a years time after they have the human dataset to prove safety and efficacy, creating a much higher-value product.

If a big pharma came to the table now, in preclinical, they could offer 5c/share or $100m for the company, a 100% premium on today's price. Seems like a good offer on paper, especially for a product that has no clinical validation in humans. Investors double their money as of today. Would they be willing to offer 10c/share ($200m), a 300% increase? Other side of the coin is what the minimum value the major shareholders are looking to get out of their investment, because they'll control the vote. Why would they accept a $200m buyout when they could wait 12 months and with supporting clinical evidence expect say 25c/share ($500m), a 900% increase.

These are all obviously hypothetical numbers I've picked out of the air and is in no way investment advice. I believe the thought process to be relatively logical though. And I agree with you that Patrys is well positioned for a buyout, My opinion is that I'd be surprised if it happens before the phase 1 trial when they're also well positioned to run the trial first. Our opinions don't have to match, I appreciate the discussion either way.

Expand

I direct your attention to:

Chairman’s Address and CEO Presentation at Annual General Meeting 5/11/2021

Page 16/23

Recent deals for antibody and DNA Damage Repair drugs

Just in case you haven't already read it. I just don't see Campbell negotiating for M$250. He didn't do the fund raiser for nothing.

PAB Price at posting: 2.2¢ Sentiment: None Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

Bitcoin: Current State of Play & Where to Next | Swyftx

Week 33 Wrap: US recession fears forgotten; RBNZ’s surprise rate cut; more iron ore trouble

VTM

Victory Metals dips -8% even as company set to grow heavy REE resource at North Stanmore

Emerald & Azure score Digger & Dealer awards

M2R

EIS co-funded campaign sees Miramar kick off maiden drilling at Bangemall, Gascoyne WA

EQR

EQ Resources transitions historic Mt Carbine tungsten mine to owner-operator system

ARD

Argent begins search for VMS mineralisation at Kempfield Cu-Pb-Zn-Au-Ag play in NSW

WNX

Wellnex sees first special access scheme prescriptions for new Wellness Life brand

IMD

IMDEX to receive $10M in out-of-court settlement with Boart Longyear over downhole tool patent

SVL

Court of Appeal upholds environmental group's challenge to Silver Mines Ltd's Bowden project

There are more pages in this discussion • 66 more messages in this thread...

First 60 Last

Add PAB (ASX) to my watchlist

(20min delay)
Last 0.6¢		Change 0.000(0.00%)		Mkt cap ! $12.34M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
6	1853666	0.6¢

Sellers (Offers)

Price($)	Vol.	No.
0.7¢	3325244	5

View Market Depth

No.	Vol.	Price($)
6	1853666	0.006
16	8715158	0.005
11	6064000	0.004
13	6400516	0.003
5	2522000	0.002

Price($)	Vol.	No.
0.007	3325244	5
0.008	2781393	7
0.009	1080000	2
0.010	396000	5
0.011	1000000	1

Last trade - 16.12pm 16/08/2024 (20 minute delay)

PAB (ASX) Chart

Day chart unavailable

I direct your attention to: Chairman’s Address and CEO...

Bitcoin: Current State of Play & Where to Next | Swyftx

Week 33 Wrap: US recession fears forgotten; RBNZ’s surprise rate cut; more iron ore trouble

Victory Metals dips -8% even as company set to grow heavy REE resource at North Stanmore

Emerald & Azure score Digger & Dealer awards

EIS co-funded campaign sees Miramar kick off maiden drilling at Bangemall, Gascoyne WA

EQ Resources transitions historic Mt Carbine tungsten mine to owner-operator system

Argent begins search for VMS mineralisation at Kempfield Cu-Pb-Zn-Au-Ag play in NSW

Wellnex sees first special access scheme prescriptions for new Wellness Life brand

IMDEX to receive $10M in out-of-court settlement with Boart Longyear over downhole tool patent

Court of Appeal upholds environmental group's challenge to Silver Mines Ltd's Bowden project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

I direct your attention to: Chairman’s Address and CEO...

Top Stories

Bitcoin: Current State of Play & Where to Next | Swyftx

Week 33 Wrap: US recession fears forgotten; RBNZ’s surprise rate cut; more iron ore trouble

Victory Metals dips -8% even as company set to grow heavy REE resource at North Stanmore

Emerald & Azure score Digger & Dealer awards

EIS co-funded campaign sees Miramar kick off maiden drilling at Bangemall, Gascoyne WA

EQ Resources transitions historic Mt Carbine tungsten mine to owner-operator system

Argent begins search for VMS mineralisation at Kempfield Cu-Pb-Zn-Au-Ag play in NSW

Wellnex sees first special access scheme prescriptions for new Wellness Life brand

IMDEX to receive $10M in out-of-court settlement with Boart Longyear over downhole tool patent

Court of Appeal upholds environmental group's challenge to Silver Mines Ltd's Bowden project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News